StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $355 at Leerink Partners
October 25, 2017 7:29 AM
Leerink Partners raised its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Biogen (BIIB) Reports AFFINITY Phase 2 Trial Initiation for Opicinumab (Anti-LINGO-1) in Multiple Sclerosis
October 25, 2017 5:56 AM
BMO Capital Upgrades Biogen (BIIB) to Outperform
October 25, 2017 1:01 AM
Biogen Announces AFFINITY Phase 2 Trial Initiation for Opicinumab (Anti-LINGO-1) in Multiple Sclerosis
October 25, 2017 1:00 AM
Form 10-Q BIOGEN INC. For: Sep 30
October 24, 2017 4:37 PM
Biogen (BIIB) Weakness Is Buying Opportunity - Goldman Sachs
October 24, 2017 2:35 PM
SPINRAZA Confusion Creates a Buying Opportunity in Biogen (BIIB) - Stifel
October 24, 2017 11:58 AM
Biogen (BIIB) Tops Q3 EPS by 61c
October 24, 2017 7:00 AM
Biogen Reports Quarterly Revenues of $3.1 Billion
October 24, 2017 6:59 AM
